Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Pulmonary Eosinophilia

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Pulmonary Eosinophilia in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komlósi, ZI1
Pozsonyi, E1
Tábi, T1
Szöko, E1
Nagy, A1
Bartos, B1
Kozma, GT1
Tamási, L1
Orosz, M1
Magyar, P1
Losonczy, G1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Pulmonary Eosinophilia

ArticleYear
Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:7

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Dexamethasone; Drug Resistance; Female; Gluco

2006